1. Pathology of human mesothelioma: etiologic and diagnostic considerations;Roggli, V.L.; Kolbeck, J.; Sanfilipo, F.; Shelbume, J.D.;Pathol Annu,1987
2. The pathology of malignant mesothelioma, including immunohistology and ultrastructure;Henderson, D.W.; Shilkin, K.B.; Whitaker, D.; Attwood, H.D.; Constance, T.J.; Steele, R.H.,1992
3. Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma;Sheibani, K.; Esteban, J.W.; Bailey, A.; Battifora, H.; Weiss, L.M.;Hum Pathol,1992
4. Immunochemistry in the differential diagnosis of effusions: use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations;Frisman, D.M.; McCarthy, W.F.; Schleiff, P.; Buckner, S.-B.; Nocito, D.; O'Leary, T.J.;Mod Pathol,1994
5. Multiplemarker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma;Brown, R.W.; Clark, G.M.; Tandon, A.T.; Allred, D.C.;Hum Pathol,1993